<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p>Retinoblastoma is a congenital malignant tumour originating from the retina of the eye. This tumour may be hereditary, particularly the bilateral form which forms about 30% of cases. Most tumours however are sporadic (spontaneous mutation). This is the third commonest cancer seen amongst children in Ghana. Most children present before five  years of age. It rarely occurs in older children. The prognosis with early presentation is excellent with a 95% chance of long term cure. There is  a high rate of development of tumours of other organs later in life in the hereditary form.</p><p><strong>CAUSES</strong></p><ul><li>Genetic (up to 40% of cases)</li><li>Sporadic (in about 60% of cases)</li></ul><p><strong>SYMPTOMS</strong></p><ul><li>White, shiny spot (leukocoria) in the pupil, also known as the cat's eye reflex is usually the first symptom in most patients</li><li>Squint (strabismus)</li><li>Visual loss</li><li>Protruding eyeball</li><li>Redness of the eye</li></ul><p><strong>SIGNS</strong></p><ul><li>Absent red reflex</li><li>Tumour in the retina on fundoscopy</li><li>Vitreous haemorrhage and retinal detachment on fundoscopy</li><li>Increased intraocular pressure (glaucoma)</li><li>Orbital cellulitis</li></ul><p><strong>INVESTIGATIONS</strong></p><ul><li>Ultrasound scan of orbit</li><li>Head CT or MRI scan</li><li>Lumbar puncture for cerebrospinal fluid cytology</li><li>Bone marrow aspirate</li></ul><p><strong>TREATMENT</strong></p><p><strong>Treatment objectives</strong></p><ul><li>To arrest the progression of the tumour</li><li>To prevent distant spread of tumour</li><li>To achieve long term cure</li><li>To provide adequate supportive and palliative care in advanced</li></ul><p>disease</p><p><strong>Non-pharmacological treatment</strong></p><ul><li>Enucleation of the affected eye is curative in the early stages</li><li>Prosthetic eye insertion</li><li>Laser therapy for focal control</li><li>Radiotherapy for local spread of the tumour</li><li>Counselling to help cope with psychological impact of the disease</li></ul><p><strong>Pharmacological treatment</strong></p><p><strong>A. Intraocular and extraocular retinoblastoma</strong></p><p>Chemotherapy Evidence Rating: [A]</p><ul><li>Vincristine, IV,</li><li>Etoposide, IV,</li><li>Carboplatin, IV,</li></ul><p><strong>Or</strong></p><ul><li>Vincristine, IV,</li><li>Etoposide, IV,</li><li>Cyclophosphamide, IV,</li></ul><p><strong>B. Advanced disease with intracranial metastases</strong></p><p>Palliative care with adequate pain and other symptom control (See section on palliative care)</p><p><strong>C. For treatment of vomiting</strong></p><p>Evidence Rating: [A]</p><ul><li>Metoclopramide, IV or oral, 100-400 microgram/kg 8 hourly</li></ul><p><strong>Or</strong></p><ul><li>Granisetron, IV, 40 microgram/kg (max. 3 mg) stat. May repeat 12 hourly if necessary</li></ul><p><strong>Or</strong></p><ul><li>Granisetron, oral, 20 microgram/kg (max. 1 mg) within 1 hour before start of treatment</li></ul><p><strong>Then</strong></p><p>20 microgram/kg 12 hourly for up to 5 days</p><p><strong>Or</strong></p><ul><li>Ondansetron, IV,</li></ul><p>Adult</p><p>5 mg/m2 stat.</p><p>Repeat 8 hourly if necessary</p><p>Children</p><p>12-18 years; 8 mg stat. (immediately before chemotherapy)</p><p><strong>Or</strong></p><ul><li>Ondansetron, oral,</li></ul><p>Adult</p><p>8 mg 8 hourly, administered 30 minutes before the start of chemo-</p><p>therapy Children</p><p>12-18 years;  8 mg 8-12 hourly up to 5 days</p><p>1-12 years; 4 mg 8-12 hourly up to 5 days</p><p><strong>D. For treatment of febrile neutropenia</strong></p><ul><li>Ceftriaxone, IV, 100 mg/kg daily</li></ul><p><strong>And</strong></p><ul><li>Gentamicin, IV, 5 mg/kg daily</li></ul><p><strong>And (if still febrile after 48 hours, add)</strong></p><ul><li>Cloxacillin, IV, 25-50 mg/kg 6 hourly</li></ul><p><strong>And (if still febrile after 5 days, add)</strong></p><ul><li>Fluconazole, oral, 10 mg/kg daily</li></ul><p><strong>E. For treatment of anaemia and thrombocytopenia</strong></p><ul><li>Blood and blood product transfusions (See section on '<a href="bleeding_disorders.html">Bleeding disorders</a>')</li></ul><p><strong>REFERRAL CRITERIA</strong></p><p>All patients should be referred to a tertiary centre that can effectively treat retinoblastoma.</p>
</body>
</html>
